Eosinophil cationic protein (ECP) in saliva: A new marker of disease activity in bronchial asthma

Respiratory Medicine

Volumn 95, Issue 8, 2001, Pages 670-675

  Schmekel, B ^a   Ahlner, J ^a   Malmstrom M ^a   Venge, P ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; Bronchial hyper responsiveness to isocapnic hyperventilation of dry cold air; Eosinophil cationic protein (ECP); Forced oscillation technique; Saliva

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; EOSINOPHIL CATIONIC PROTEIN; GLUCOCORTICOID; LONG ACTING DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; ASTHMA; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DISEASE MARKER; DOSE RESPONSE; EOSINOPHIL; FEMALE; HUMAN; MALE; MONITORING; PATHOGENESIS; PRIORITY JOURNAL; RECORDING; REPRODUCIBILITY; SALIVA LEVEL; TIME; VOLUNTEER;

EID: 0034858979     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1123     Document Type: Article

References (34)

1. Use of induced sputum cell counts to investigate airway inflammation in asthma
2. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects
3. The eosinophil and its role in asthma
4. Sensitivity and specificity of bronchial provocation testing. An evaluation of four techniques in exercise-induced bronchospasm
5. The diagnostic capacity of forced oscillation-and forced expiration techniques: Isocapnic hyperventilation of cold air
6. Impulse Oscillometry: Analysis of Lung Mechanics in General Practice and the Clinical, Epidemiological and Experimental research
7. Lung function measurement in awake young children
8. Reference values for respiratory function tests in males: Prediction formulas with tobacco smoking parameters
9. Reference values for lung function tests in females. Regression equations with smoking variables
10. Terminology for measurements of ventilatory capacity
11. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo
12. Eosinophils, T-lymphocytes, mastcells, neutrophils, and macrophages in bronchial biopsy specimens from asthmatic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and and relationship to bronchial hyperresponsiveness
13. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EGI and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma
14. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
15. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways
16. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects
17. Airway-like inflammation of minor salivary glands in bronchial asthma
18. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia
19. Comparison between eosinophilic markers in induced sputum and blood in asthmatic patients
20. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD
21. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline
22. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma
23. Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma
24. Forced oscillation technique and spirometry in cold air provocation tests
25. Asthma, bronchial hypereactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity
26. Relationship between activated eosinophils of the bronchial mucosa and serum eosinophil cationic protein in atopic asthma
27. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
28. Nonspecific bronchial hyperresponsiveness to inhaled histamine and hyperventilation of cold dry air in subjects with respiratory symptoms of uncertain etiology
29. Hyperventilation-induced asthma: Evidence for two mechanisms
30. Repeatability and method comparison
31. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects
32. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects
33. Kinetic retrieval of eosinophil cationic protein, hyaluronan, secretory IgA, albumin, and urea during BAL in healthy subjects
34. Albumin is not suitable as a marker of bronchoalveolar lavage dilution in interstitial lung disease